Pro12Ala variant of the PPARG2 gene increases body mass index: An updated meta-analysis encompassing 49,092 subjects

Obesity

Volumn 21, Issue 7, 2013, Pages 1486-1495

  Galbete, C ^a   Toledo, E ^a   Martinez Gonzalez M A ^a   Martinez J A ^a   Guillen Grima F ^a   Marti, A ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2;

AGED; ALLELE; ARTICLE; BODY MASS; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PPARG2 GENE;

EID: 84881556630     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20150     Document Type: Article

References (30)

1. Razquin C, Martinez JA, Martinez-Gonzalez MA, et al,. The Mediterranean diet protects against waist circumference enlargement in 12Ala carriers for the PPARgamma gene: 2 years' follow-up of 774 subjects at high cardiovascular risk. Br J Nutr 2009; 102: 672-679.
2. Ereqat S, Nasereddin A, Azmi K, Abdeen Z, Amin R,. Impact of the Pro12Ala polymorphism of the PPAR-gamma 2 gene on metabolic and clinical characteristics in the Palestinian type 2 diabetic patients. PPAR Res 2009; 2009: 874126.
3. Morini E, Tassi V, Capponi D, et al,. Interaction between PPARgamma2 variants and gender on the modulation of body weight. Obesity (Silver Spring) 2008; 16: 1467-1470.
4. Razquin C, Marti A, Martinez JA,. Evidences on three relevant obesogenes: MC4R, FTO and PPARgamma. Approaches for personalized nutrition. Mol Nutr Food Res 2011; 55: 136-149.
5. Masud S, Ye S,. Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis. J Med Genet 2003; 40: 773-780.
6. Tonjes A, Scholz M, Loeffler M, Stumvoll M,. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care 2006; 29: 2489-2497.
7. Rothman K, Sander G, Timothy L,. Meta-Analysis. Modern Epidemiology. (3rd ed.) Philadelphia: Lippincott Williams & Wilkins; 2008. p. 757.
8. Martinez-Gonzalez MA, Sanchez-Villegas A, De Irala J, Marti A, Martinez JA,. Mediterranean diet and stroke: objectives and design of the SUN project. Seguimiento Universidad de Navarra. Nutr Neurosci 2002; 5: 65-73.
9. Segui-Gomez M, de la Fuente C, Vazquez Z, de Irala J, Martinez-Gonzalez MA,. Cohort profile: the 'Seguimiento Universidad de Navarra' (SUN) study. Int J Epidemiol 2006; 35: 1417-1422.
10. Bes-Rastrollo M, Perez Valdivieso JR, Sánchez-Villegas A, Alonso A, Martinez-Gonzalez MA,. Validaciõn del peso e indice de masa corporal auto-declarados de los participantes de una cohorte de graduados universitarios. Rev Esp Obes 2005; 183-189.
11. Chuang LM, Hsiung CA, Chen YD, et al,. Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance. J Mol Med (Berl) 2001; 79: 656-664.
12. Kuliczkowska J, Filus A, Trzmiel A, et al,. PPAR-gamma2 Pro12Ala polymorphism in the population of obese and non-obese men of the city of Wroclaw. Endokrynol Pol 2008; 59: 312-315.
13. Ostergard T, Ek J, Hamid Y, et al,. Influence of the PPAR-gamma2 Pro12Ala and ACE I/D polymorphisms on insulin sensitivity and training effects in healthy offspring of type 2 diabetic subjects. Horm Metab Res 2005; 37: 99-105.
14. Pisabarro RE, Sanguinetti C, Stoll M, Prendez D,. High incidence of type 2 diabetes in peroxisome proliferator-activated receptor gamma2 Pro12Ala carriers exposed to a high chronic intake of trans fatty acids and saturated fatty acids. Diabetes Care 2004; 27: 2251-2252.
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
16. Benjamini Y, Hochberg Y,. Controlling the false discovert rate-a practical and powerful approach to multiple testing. J R Stat Soc Ser B-Methodol 1995; 57: 289-300.
17. Razquin C, Martinez JA, Martinez-Gonzalez MA, et al,. A Mediterranean diet rich in virgin olive oil may reverse the effects of the -174G/C IL6 gene variant on 3-year body weight change. Mol Nutr Food Res 2010; 54 Suppl 1: S75-S82.
18. Golder S, Loke YK, Bland M,. Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: Methodological overview. PLoS Med 2011; 8: e1001026.
19. Speakman JR, Levitsky DA, Allison DB, et al,. Set points, settling points and some alternative models: theoretical options to understand how genes and environments combine to regulate body adiposity. Dis Model Mech 2011; 4: 733-745.
20. Speliotes EK, Willer CJ, Berndt SI, et al,. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010; 42: 937-948.
21. Gonzalez Sanchez JL, Serrano Rios M, Fernandez Perez C, Laakso M, Martinez Larrad MT,. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur J Endocrinol 2002; 147: 495-501.
22. Memisoglu A, Hankinson SE, Manson JE, Colditz GA, Hunter DJ,. Lack of association of the codon 12 polymorphism of the peroxisome proliferator- activated receptor gamma gene with breast cancer and body mass. Pharmacogenetics 2002; 12: 597-603.
23. Ben Ali S, Ben Yahia F, Sediri Y, et al,. Gender-specific effect of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma-2 gene on obesity risk and leptin levels in a Tunisian population. Clin Biochem 2009; 42: 1642-1647.
24. Interantional HapMap Project. Available from: http://hapmap.ncbi.nlm.nih. gov/index.html.en.
25. Lindi VI, Uusitupa MI, Lindstrom J, et al,. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes 2002; 51: 2581-2586.
26. Franks PW, Jablonski KA, Delahanty L, et al,. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia 2007; 50: 2451-2460.
27. Adamo KB, Dent R, Langefeld CD, et al,. Peroxisome proliferator-activated receptor gamma 2 and acyl-CoA synthetase 5 polymorphisms influence diet response. Obesity (Silver Spring) 2007; 15: 1068-1075.
28. Nicklas BJ, van Rossum EF, Berman DM, et al,. Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes 2001; 50: 2172-2176.
29. Matsuo T, Nakata Y, Katayama Y, et al,. PPARG genotype accounts for part of individual variation in body weight reduction in response to calorie restriction. Obesity (Silver Spring) 2009; 17: 1924-1931.
30. Bloss CS, Madlensky L, Schork NJ, Topol EJ,. Genomic information as a behavioral health intervention: Can it work? Per Med 2011; 8: 659-667.